Search Results - Edward Gane
- Showing 1 - 20 results of 95
- Go to Next Page
-
1
The natural history of recurrent hepatitis C and what influences this by Edward Gane
Published 2008Revisão -
2
Future anti‐<scp>HBV</scp> strategies by Edward Gane
Published 2017Revisão -
3
-
4
Management of chronic viral hepatitis before and after renal transplantation by Edward Gane, Helen Pilmore
Published 2002Revisão -
5
-
6
-
7
-
8
Once daily ledipasvir/sofosbuvir fixed‐dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection by Catherine Stedman, Robert H. Hyland, Xiao Ding, Phillip S. Pang, John G. McHutchison, Edward Gane
Published 2015Artigo -
9
-
10
-
11
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis by Savino Bruno, Mitchell L. Shiffman, Stuart K. Roberts, Edward Gane, Diethelm Messinger, Stephanos J. Hadziyannis, Patrick Marcellin
Published 2009Artigo -
12
-
13
-
14
-
15
-
16
Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation by Anna Dare, Lindsay D. Plank, Anthony R. J. Phillips, Edward Gane, Barry Harrison, David Orr, Yannan Jiang, Adam S. J. R. Bartlett
Published 2014Artigo -
17
-
18
No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection: Table 1. by Mark Sulkowski, Wan‐Long Chuang, Jia‐Horng Kao, Jenny C. Yang, Bing Gao, Diana M. Brainard, Kwang‐Hyub Han, Edward Gane
Published 2016Artigo -
19
-
20
Search Tools:
Related Subjects
Medicine
Internal medicine
Virus
Gastroenterology
Virology
Hepatitis C virus
Immunology
Ribavirin
Hepatitis C
Sofosbuvir
Hepatitis B virus
Cirrhosis
Hepatitis B
Chronic hepatitis
Liver transplantation
Transplantation
Biology
HBsAg
Adverse effect
Gene
Clinical endpoint
Hepatocellular carcinoma
Clinical trial
Environmental health
Genotype
Lamivudine
Oncology
Randomized controlled trial
Surgery
HBeAg